GSK-3965193

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameGSK-3965193
Drug Alias NameGSK-3965193
ClassificationSmall molecules
Mechanisms of ActionTerminal nucleotidyltransferase 4B inhibitorsTerminal nucleotidyltransferase 4A inhibitors
TargetsTerminal nucleotidyltransferase 4BTerminal nucleotidyltransferase 4A
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaThailandItaly +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A